John Gordon Freund Collegium Pharmaceutical, Inc (COLL) insider trading activity

John Gordon Freund is Director of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 70,658 shares of COLL, which is worth approximately $2.18 Million. The most recent transaction as insider was on Jun 09, 2025, when has been sold 6,601 shares (Common Stock) at a price of $30.62 per share, resulting in proceeds of $202,122. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.7K

34.67% 3M change

34.67% 12M change

Total Value Held $2.18 Million

John Gordon Freund Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2025	SELL Open market or private sale	$202,122 $30.62 p/Share	6,601 Reduced 8.54%	70,658 Common Stock
Jun 09 2025	BUY Exercise of conversion of derivative security	$201,750 $13.45 p/Share	15,000 Added 16.26%	77,259 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	9,791 Added 13.59%	62,259 Common Stock
May 16 2024	BUY Grant, award, or other acquisition	-	7,693 Added 12.79%	52,468 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	9,792 Added 17.94%	44,775 Common Stock
May 19 2022	BUY Grant, award, or other acquisition	-	14,035 Added 28.63%	34,983 Common Stock
May 20 2021	BUY Grant, award, or other acquisition	-	9,941 Added 32.18%	20,948 Common Stock

Also insider at

SIBN

SI-BONE, Inc. Healthcare

STRO

SUTRO BIOPHARMA, INC. Healthcare

JGF